Rapid Tests and Point of Care Market to 2017 – Clinical Chemistry Tests to be the Major Revenue Generator
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Rapid Tests and Point of Care Market Forecast to Increase at a CAGR of 7% During the Period 2010–2017
2.2 Significant Consolidation in Recent Years to Reshape the Competitive Landscape in the Industry
2.3 Clinical Chemistry Rapid Tests and POC to Continue to be the Largest Segment in the Global Rapid Tests and Point of Care Market
3 Introduction
3.1 GBI Research Guidance
4 Global Rapid Tests and Point of Care Market: Market Characterization
4.1 Global Rapid Tests and Point of Care Market, Revenue ($m), 2003 – 2010
4.2 Global Rapid Tests and Point of Care Market, Revenue ($m), 2010 – 2017
4.3 Global Rapid Tests and Point of Care Market, Key Market Trends
4.3.1 Decentralization of Laboratories is a Growing Trend Across the World
4.3.2 Integration of POC Devices with Hospital Information Systems is a Growing Trend
4.3.3 Significant Consolidation in Recent Years to Reshape the Competitive Landscape of the Industry
4.3.4 Increased Demand for Rapid Tests and POC Testing in Emerging Countries Will Drive the Growth of the Market in the Near Future
4.4 Global Rapid Tests and Point of Care, Market Dynamics
4.4.1 Global Rapid Tests and Point of Care, Market Drivers
4.4.1.1 Continuing Improvements in Rapid Tests and POC Testing to Drive Market Growth
4.4.1.2 Advantages of Rapid Tests and POC Testing Over Traditional Laboratory Testing are Driving Market Growth
4.4.1.3 Expanded Menu of Point of Care Tests Will Result in Increased Usage of POC Testing, Leading to the Growth of the POC Tests and Rapid Tests Market
4.4.1.4 Increasing Prevalence of Infectious Diseases to Drive the Rapid Tests and POC Market Globally
4.4.2 Global Rapid Tests and Point of Care, Market Restraints
4.4.2.1 Pricing Pressures to Adversely Affect the Revenues of the Rapid Test and POC Test Industry
4.4.2.2 High Per Test Cost of Rapid Tests and POC Tests to Hinder Market Growth
4.4.2.3 Drawbacks Associated with POC Devices to Hinder Adoption Significantly
4.4.2.4 Complexity of Data Management and Error Management to Hinder Market Growth
5 Global Rapid Tests and Point of Care Market: Market Category Analysis and Forecasts
5.1 Clinical Chemistry Rapid Tests and POC
5.1.1 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010
5.1.2 Clinical Chemistry Rapid Tests and POC Market, Global, Revenue Forecasts ($m), 2010–2017
5.2 Clinical Chemistry Rapid Tests and POC Market: Market Dynamics
5.2.1 Clinical Chemistry Rapid Tests and POC Market: Market Drivers
5.2.1.1 Increase in Percentage of Population Seeking Critical Care Will Drive the Clinical Chemistry Rapid Tests and POC Tests Market
5.2.1.2 Technological Advancements to Drive the Clinical Chemistry Rapid Tests and POC Tests Market
5.2.2 Clinical Chemistry Rapid Tests and POC Market: Market Restraints
5.2.2.1 Poor Sensitivity and Poor Specificity of Test Strips for Some Analytes to Slow Down Market Growth
5.3 Immunochemistry Rapid Tests Market
5.3.1 Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003 – 2010
5.3.2 Immunochemistry Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 – 2017 31
5.4 Immunochemistry Rapid Tests Market: Market Dynamics
5.4.1 Immunochemistry Rapid Tests Market: Market Drivers
5.4.1.1 Lateral Flow Assays to Drive the Immunochemistry Rapid Tests Market
5.4.1.2 Technological Advancements Such as Microfluidics in Rapid Immunoassays to Drive Market Growth
5.4.1.3 Wide Range of Immunoassay Applications to Drive the Immunochemistry Rapid Tests Market
5.4.2 Immunochemistry Rapid Tests Market: Market Restraints
5.4.2.1 Limitations Such as Low Sensitivity of Immuno Assays to Hinder Market Growth
5.5 Hematology Rapid Tests Market
5.5.1 Hematology Rapid Tests Market, Global, Revenue ($m), 2003 – 2010
5.5.2 Hematology Rapid Tests Market, Global, Revenue Forecasts ($m), 2010 – 2017
5.6 Hematology Rapid Tests Market: Market Dynamics
5.6.1 Hematology Rapid Tests Market: Market Drivers
5.6.1.1 Availability of Innovative Rapid Test Devices to Drive Market Growth
5.6.1.2 Blood Spot Tests to Drive the Growth of the Hematology Rapid Tests Market
5.6.2 Hematology Rapid Tests Market: Market Restraints
5.6.2.1 Limitations Such as Low Target Sensitivity and Small Volume of Dried Blood Spots to Slow Down Adoption Rates in the Near Future
6 Global Rapid Tests and Point of Care Market: Country Analysis and Forecasts
6.1 Rapid Tests and Point of Care Market: Cross–Country Analysis
6.2 Revenue Forecasts, by Country, 2003 – 2017
6.2.1 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003 – 2010
6.2.2 Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010 – 2017
6.2.3 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003 – 2010
6.2.4 Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010 – 2017
6.2.5 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003 – 2010
6.2.6 Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010 – 2017
6.2.7 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010
6.2.8 Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010–2017
6.2.9 Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010
6.2.10 Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017
6.2.11 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010
6.2.12 Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017
6.2.13 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010
6.2.14 Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017
6.2.15 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010
6.2.16 Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017
6.2.17 Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010
6.2.18 Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017
6.2.19 Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010
6.2.20 Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017
6.2.21 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010
6.2.22 Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017
6.2.23 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003–2010
6.2.24 Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017
7 Global Rapid Tests and Point of Care Market: Key Market Participants
7.1 F. Hoffmann–La Roche Ltd.
7.1.1 Business Overview
7.1.2 Marketed Products
7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Marketed products
7.3 Siemens Healthcare (Subsidiary of Siemens AG)
7.3.1 Business Overview
7.3.2 Marketed Products
7.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
7.4.1 Business Overview
7.4.2 Marketed Products:
7.5 bioMerieux S.A. (Subsidiary of Merieux Alliance Group)
7.5.1 Business Overview
7.5.2 Marketed products
7.6 DiaSorin S.p.A
7.6.1 Business Overview
7.6.2 Marketed Products:
8 Global Rapid Tests and Point of Care Market: Product Pipeline Analysis
8.1 Rapid Tests and Point of Care Market: Pipeline Product Summary
8.2 Rapid Tests and Point of Care Market: List of Pipeline Products
8.3 Rapid Tests and Point of Care: Profiles of Key Pipeline Products
8.3.1 ImmProCon Technology
8.3.2 RAPIDPoint 500 System – Lactate Assay
8.3.3 Sali–Chek Reader
8.3.4 Point Of Care Diagnostic Device
8.3.5 ACE Alera Clinical Chemistry System – Direct A1c Assay
8.3.6 Advia 120 Hematology System – IRF Test
8.3.7 AIA–600 II – D–dimer Test
9 Global Rapid Tests and Point of Care Market: Consolidation Landscape
9.1 Rapid Tests and Point of Care Market: Key Deals 2011
9.1.1 Sony Corporation of America Acquires Micronics
9.1.2 Roche Completes Acquisition of MTM Laboratories
9.1.3 Quest Diagnostics Completes Acquisition of Athena Diagnostics
9.1.4 Danaher Completes Acquisition of Beckman Coulter
9.2 Rapid Tests and Point of Care Market: Key Deals, 2007–2010
9.2.1 Merck Completes Acquisition of Millipore
9.2.2 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics
9.2.3 Inverness Medical Innovations Completes Acquisition of Concateno from Marwyn
9.2.4 bioMerieux Acquires AviaraDx
9.2.5 Siemens Medical Acquires Dade Behring
9.2.6 Roche Acquires Ventana Medical Systems
9.2.7 Bio–Rad Laboratories Acquires Diamed
10 Appendix
10.1 Definitions
10.1.1 Clinical Chemistry Rapid Tests & POC
10.1.2 Immunochemistry Rapid Tests Market
10.1.3 Haematology Rapid Tests Market
10.2 Sources
10.3 Acronyms
10.4 Research Methodology
10.4.1 Secondary Research
10.4.2 Primary Research
10.4.3 Models
10.4.4 Forecasts
10.4.5 Expert Panels
10.5 Contact Us
10.6 Disclaimer
List of Tables
Table 1 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003–2010
Table 2 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010–2017
Table 3 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010
Table 4 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010–2017
Table 5 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010
Table 6 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017
Table 7 : Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010
Table 8 : Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017
Table 9 : Rapid Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003–2017
Table 10 : Rapid Tests and Point of Care Market, the US, Revenue ($m), 2003–2010
Table 11 : Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010–2017
Table 12 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003–2010
Table 13 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010–2017
Table 14 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003–2010
Table 15 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010–2017
Table 16 : Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010
Table 17 : Rapid Tests and Point of Care Market, the Germany, Revenue ($m), 2010–2017
Table 18 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010
Table 19 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017
Table 20 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010
Table 21 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017
Table 22 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010
Table 23 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017
Table 24 : Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010
Table 25 : Rapid Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017
Table 26 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010
Table 27 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017
Table 28 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010
Table 29 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017
Table 30 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010
Table 31 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017
Table 32 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010
Table 33 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017
Table 34 : Rapid Tests and Point of Care Market, Global, Pipeline Product Summary, 2010
Table 35 : Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage
Table 36 : Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010–11
Table 37 : Rapid Tests and Point of Care Market, Global, List of Pipeline Products, 2010–12
Table 38 : ImmProCon Technology, Product Status, 2011
Table 39 : RAPIDPoint 500 System, Product Status, 2011
Table 40 : Sali–Chek Reader, Product Status, 2011
Table 41 : Point Of Care Diagnostic Device, Product Status, 2011
Table 42 : ACE Alera Clinical Chemistry System – Direct A1c Assay, Product Status, 2011
Table 43 : Advia 120 Hematology System – IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011
Table 44 : Advia 2120 Hematology System – MPC (Mean Platelet Component) Test, Product Status, 2011
Table 45 : AIA (Automated Immunoassay Analyzer)–600 II – D–dimer Test, Product Status, 2011
List of Figures
Figure 1 : Rapid Tests and Point of Care Market, Global, Revenue ($bn), 2010–2017
Figure 2 : Clinical Chemistry Rapid Tests and POC, Global, Segment–Wise Revenue, ($m), 2010
Figure 3 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2003–2010
Figure 4 : Rapid Tests and Point of Care Market, Global, Revenue ($m), 2010–2017
Figure 5 : Rapid Tests and Point of Care Market, Market Categorization and Segmentation
Figure 6 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2003–2010
Figure 7 : Clinical Chemistry Rapid Tests and POC Market, Global, Revenue ($m), 2010–2017
Figure 8 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2003–2010
Figure 9 : Immunochemistry Rapid Tests Market, Global, Revenue ($m), 2010–2017
Figure 10 : Hematology Rapid Tests Market, Global, Revenue ($m), 2003–2010
Figure 11 : Hematology Rapid Tests Market, Global, Revenue ($m), 2010–2017
Figure 12 : Tests and Point of Care Market, Global, Cross Country Analysis, CAGR (%), 2003–2017
Figure 13 : Tests and Point of Care Market, the US, Revenue ($m), 2003–2010
Figure 14 : Rapid Tests and Point of Care Market, the US, Revenue ($m), 2010–2017
Figure 15 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2003–2010
Figure 16 : Rapid Tests and Point of Care Market, Canada, Revenue ($m), 2010–2017
Figure 17 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2003–2010
Figure 18 : Rapid Tests and Point of Care Market, the UK, Revenue ($m), 2010–2017
Figure 19 : Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2003–2010
Figure 20 : Rapid Tests and Point of Care Market, Germany, Revenue ($m), 2010–2017
Figure 21 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2003–2010
Figure 22 : Rapid Tests and Point of Care Market, France, Revenue ($m), 2010–2017
Figure 23 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2003–2010
Figure 24 : Rapid Tests and Point of Care Market, Italy, Revenue ($m), 2010–2017
Figure 25 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2003–2010
Figure 26 : Rapid Tests and Point of Care Market, Spain, Revenue ($m), 2010–2017
Figure 27 : Tests and Point of Care Market, Japan, Revenue ($m), 2003–2010
Figure 28 : Tests and Point of Care Market, Japan, Revenue ($m), 2010–2017
Figure 29 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2003–2010
Figure 30 : Rapid Tests and Point of Care Market, China, Revenue ($m), 2010–2017
Figure 31 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2003–2010
Figure 32 : Rapid Tests and Point of Care Market, India, Revenue ($m), 2010–2017
Figure 33 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2003–2010
Figure 34 : Rapid Tests and Point of Care Market, Australia, Revenue ($m), 2010–2017
Figure 35 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2003-2010
Figure 36 : Rapid Tests and Point of Care Market, Brazil, Revenue ($m), 2010–2017
Figure 37 : Rapid Tests and Point of Care Market, Global, Pipeline Product Summary (%), 2010
Figure 38 : Rapid Tests and Point of Care Market, Pipeline Assessment, by Development Stage